Morbidity and Mortality Following Short Course Preoperative Radiotherapy in Rectal Carcinoma
-
Farshid Farhan
,
Mohammad Sadegh Fazeli
,
Farhad Samiei
,
Mahdi Aghili
,
Peiman Haddad
,
Somayeh Gholami
,
Mansoureh Nabavi
Abstract
The aim of this study was to evaluate the morbidity and mortality in patients with operable stage II and III rectal cancers within one or two months after surgery, who has been treated pre-operatively with short course radiotherapy. Twenty-eight patients with rectal adenocarcinoma, consecutively referred to the Cancer Institute of Imam Khomeini Hospital from March 2009 to March 2010, were selected for the study after staging by endorectal ultrasound and CT of abdomen, pelvis, and chest; and if they had inclusion criteria for short course schedule, they were treated with radiotherapy alone at 2500 cGy for 5 sessions, and then they were referred to the surgical service for operation one week later. They were visited there by a surgeon unaware of the research who completed a questionnaire about pre-operative, operative, and post-operative complications. Of 28 patients, 25 patients underwent either APR or LAR surgery with TME. One patient developed transient anal pain grade I and one patient had dysuria grade I; they were improved in subsequent follow-up. Short course schedule can be performed carefully in patients with staged rectal cancer without concerning about serious complications. This shorter treatment schedule is cost-effective and would be more convenient for patients due to fewer trips to the hospital and the main treatment, i.e. operating the patient, will be done with the shortest time the following diagnosis.
Mousavi SM, Gouya MM, Ramazani R, et al. Cancer incidence and mortality in Iran. Ann Oncol 2009;20(3):556-63.
Annals of Oncology. Educational Book of the 31st ESMO Congress 2006; x129-x32.
Sauer R. Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer. Pathol Oncol Res 2002;8(1):7-17.
Perez GA, editor. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia: LWW; 2013: p. 1226.
Gerard A, Buyse M, Nordlinger M, et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 1988;208(5):606-14.
Stockholm Rectal Cancer Study Group. Preoperative shortterm radiation therapy in operable rectal carcinoma. Cancer 1990;66(1):49-55.
Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36(6):564-72.
Martling AL, Holm T, Johansson H, et al. The Stockholm II Trial on preoperative radiotherapy in rectal carcinoma. Long-term follow-up of a population- based study. Cancer 2001;92(4):896-902.
Folkesson J, Birgisson H, Påhlman L, et al. The Swedish Rectal Cancer Trial: Long-lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23(4):5644-50.
Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomized trial. Lancet 2009;373(9666):811-20.
Hartley A, Giridharan S, Gray L, et al. Retrospective study of acute toxicity following short-course preoperative radiotherapy. Br J Surg 2002;89(7):889-95.
Korkolis DP, Plataniotis GD, Gondikakis E, et al. Shortterm preoperative radiotherapy is a safe approach for the treatment of locally advanced rectal cancer. Int J Colorectal Dis 2006;21(1):1-6.
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93(10):1215-23.
Marijnen CA, Kapiteijn E, van de Velde CJH, et al. Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial. J Clin Oncol 2002;20(3):817-25.
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectalexcision for resectable rectal cancer. N Engl J Med 2001;345(9):638-46.
Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with TME for rectal cancer: increased bowel dysfunction in irradiated patients-A Dutch Colorectal cancer Group Study. J Clin Oncol 2005;23(25):6199-206.
Ngan SY, Burmeister B, Fisher RJ, et al. Randomized Trial of Short-Course Radiotherapy versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 2012;31(31):3827-33.
Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62(3):752-60.
Veenhof AA, Bloemena E, Engel AF, et al. The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer. Int J Colorectal Dis 2009;24(9):1091-6.
Vironen J, Juhola M, Kairaluoma M, et al. Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. Int J Colorectal Dis 2005;20(5):440-5.
| Files | ||
| Issue | Vol 53, No 10 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Rectal carcinoma Short-course preoperative radiotherapy | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
